ABTEST© Card Clinical Perfomance Study

Status Completed

Clinical Trial Summary

The study confirms the performance equivalence of the in vitro Diagnostic reagent ABTEST card used with the new reformulated WS solution

Clinical Trial Description

The study consists to perform on 100 patients a first pre transfusional control with the reference in vitro reagent ABTEST card (CE Marked reagent) followed by a another pre transfusional control with the in vitro reagent ABTEST card in study (new reformulated WS solution used) . ;

Study Design

Related Conditions & MeSH terms

Transfusion Reaction

Clinical Trial Details

NCT number	NCT05140395
Study type	Interventional
Source	Diagast
Contact
Status	Completed
Phase	N/A
Start date	June 6, 2021
Completion date	November 4, 2021

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT03885570` - Blood Transfusion Management in Patients With Mitral Valve Replacement in China
Withdrawn	`NCT03056378` - POOLED Red Blood Cells Prepared From Pooling 5 Leukoreduced, Irradiated RBC Units	Phase 1
Completed	`NCT02423135` - Detection of Autologous DEHP (DiEthylHexyl Phthalate)-Free Blood Transfusion in Anti-doping	N/A
Completed	`NCT02200692` - Allergic Transfusion Reactions in Plasma Transfusion
Completed	`NCT02841111` - Old Red Blood Cell In Renal Transplantation	N/A
Completed	`NCT04267029` - Transfusion Associated Dyspnea Profiling
Completed	`NCT02607150` - Changes in Cerebral Oxygenation During the Administration of Cell Saver Blood and Allogeneic Blood	N/A
Recruiting	`NCT03855644` - Blood Transfusion Among Patients With Pelvic Fracture in China
Active, not recruiting	`NCT03182491` - Mechanisms of Anaphylaxis